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EDITORIAL REVIEW
Renal antioxidant enzymes: Their regulation and function
Over the last decade, experimental evidence has been
amassed to indicate that partially reduced oxygen, more gener-
ally termed reactive oxygen metabolites, play a key intermedi-
ary role in the pathophysiologic processes of a surprisingly wide
variety of clinical and experimental renal diseases. These range
from acute to chronic—and from immune to non-immune—
injuries, making the kidney unique among other organs as the
site in which a spectrum of seemingly unrelated diseases, from
minimal change disease to obstructive nephropathy, involves
reactive oxygen metabolites (Table 1) [1—17]. In some forms of
these injuries, resident renal cells [11, 13, 14], in addition to
polymorphonuclear neutrophils and other circulating cells
[8—10], can be the source of reactive oxygen metabolites. Thus,
cultured glomerular mesangial cells have been shown to pro-
duce reactive oxygen metabolites when exposed to complement
membrane attack complexes C5b-9 [12, 15], which are formed
in an experimental model of immune glomerular injury. The
current notion of reactive oxygen metabolites as ubiquitous
renal pathogenic agents is supported by two lines of experimen-
tal evidence, namely, (1) detection of products of oxidant injury
in renal tissue or urine, and (2) experimental demonstration of a
protective effect of metabolic inhibitors of oxygen radicals in
those disease settings. For example, in both hemoglobin- and
myoglobin-induced acute renal failure, deferoxamine, an iron
chelator, prevented lipid peroxidation and acute renal failure
[17]. These results were taken to indicate that hydroxyl radicals
are involved in these pigment-induced acute renal failures. Of
note, however, many of the metabolites measured and some of
the inhibitors administered in many of the above experiments
are not highly specific to particular types of oxygen radicals nor
to the injuries driven by oxygen radicals. In fact, most recent
experimental findings [18-20] are in line with the notion that
more restricted types of oxygen radicals are involved in more
limited phases/modes of renal injuries than suggested earlier.
Thus, tissue injury following renal ischemia represents the
injurious effects of both reactive oxygen metabolites [16] and
anoxia/hypoxia [19] in varying degrees, depending on the
duration and the mode of ischemia.
Of note, analogous to infectious diseases, systemic or local,
the manifestation of antioxidant enzymes in renal diseases is
determined by the dynamic balance between the pathogen and
intrinsic defense mechanisms. Although several antioxidant
enzymes (AOEs) have been identified, and their molecular
structure, regulation, and reactions extensively studied, some
are less characterized. In concert with other defense mecha-
nisms, these enzymes protect cells against the toxic effect of
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reactive oxygen metabolites. Although it is currently not pos-
sible to give a meaningful estimate of the quantitative impor-
tance of each of these enzymes, quantitative assessment of the
role of AOEs in the kidney is possible. The limitations of
quantitative efforts arise from both current technological limi-
tations and the specific nature of the reactive oxygen metabo-
lites and AOEs. Because biological membranes are permeable
to oxidants and their metabolites, offending pathogens can
reach their targets without hindrance [21], although many of the
antioxidants are reasonably compartmentalized. Thus, the site
of oxidant injury may be distant from the site of oxygen
generation, while the site of antioxidant action may be remote
from both oxidant generation and injury. Moreover, antioxidant
enzymes of different classes are complementary to each other
[22, 23], further obfuscating efforts to quantify the contribution
of each enzyme. In this article, we will provide an overview of
the current understanding of the antioxidant enzyme system in
the kidney. Discussion is limited for some enzymes, and some
data are still preliminary.
Supplementation of endogenous antioxidant enzymes protects
kidneys from a variety of injuries
Prototypically, both of the above-discussed types of evidence
exist for the experimental model of minimal change nephrotic
syndrome [2, 4, 5, 24, 25]. This model, induced by administra-
tion of puromycin aminonucleoside, is characterized by mas-
sive proteinuria and glomerular lesions that are ultrastructurally
and biochemically identical to those of human minimal change
disease. Markedly elevated levels of xanthine oxidase activity
(localized in the glomerulus) [26, 27] and aldehyde (a non-
specific lipid peroxidation product) were detected in glomeruli
isolated from the kidney during the height of massive protein-
uria and abnormal epithelial cell morphology, that is "fusion of
foot processes" [25]. Concurrent exogenous administration of
an antioxidant enzyme, for example, superoxide dismutase
(SOD) [2, 3] or catalase [3], was highly effective in attenuating
the functional and structural abnormality of this model. The
effectiveness of these specific antioxidant enzymes has been
demonstrated in many other experimental disease models,
including ischemialreperfusion injury, although some results
are not entirely consistent. As the nephrotoxicity of oxidants
per se is beyond the scope of the present article, the reader is
referred to excellent recent review articles [4, 7, 28—31] discuss-
ing in depth these results in other models.
Endogenous antioxidant enzymes: Nature's cellular defense
mechanism against oxidant injury
Of note, reactive oxygen metabolites are constant products of
normal aerobic cell metabolism. Thus, auto-oxidations of var-
ious organic substances, such as hydroquinones, produce su-
peroxide anion. Membrane-bound cytochromes (P450 and bS)
located in the endoplasmic reticulum generate superoxide anion
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Table 1. Clinical renal disease entities in which oxidants are
considered to be pathogenic
Glomerular disease
Minimal change disease
Membranous glomerulopathy
Neutrophil-dependent injurya
Acute renal failure
Post-ischemic
Toxic"
Obstructive nephropathy
Pyelonephritis
Progressive renal failure
a Includes anti-GBM nephritisb Includes: cis-platinum; gentamicin; contrast media; HUS; myoglo-
binuria/hemoglobinuria; radiation
by auto-oxidation (Fig. 1). The cytochrome-catalyzed genera-
tion of superoxide anion from oxygen is particularly active in an
environment in which the concentrations of electron donors,
such as NADPH and NADH, are relatively high (Fig. 1).
Arachidonic acid metabolisms of cyclooxygenase and 5-lipoxy-
genase pathways, which are involved in a variety of fundamen-
tal cell functions, also produce partially reduced oxygen mole-
cules. However, cells which are under constant threat of the
toxic effect of reactive oxygen species are furnished with highly
effective devices to eliminate these toxic oxygen species. A
major mechanism of this elimination is the antioxidant enzyme
cascade [27]. Superoxide dismutases (SODs), catalase and
glutathione peroxidase, serve to eliminate primary products of
partially reduced oxygen (Fig. 1). SODs are found mainly in the
intracellular compartment. They exist as Mn-containing pro-
teins primarily in the mitochondrial matrix but are found in
cytosol, as well [32], and as CulZn-containing enzymes primar-
ily in the cytoplasm; they also exist in lesser quantities in
lysosomes [33] and the mitochondrial intermembrane space
[34]. In addition, SODs are present at low concentrations in
extracellular fluids [35]. By binding to heparan sulfate proteo-
glycans on endothelial cells, these extracellular SODs are
speculated to function as a "protective coat" [36]. These
different forms of superoxide dismutase promote the same
biochemical reaction, that is, the dismutation of the superoxide
anion, which is an immediate oxygen metabolite with a high
biologic activity, to yield hydrogen peroxide and oxygen.
Hydrogen peroxide is removed by hydroperoxidases (such as,
glutathione peroxidase), but this can give rise to the extremely
toxic hydroxyl radical in the presence of reduced iron, which is
also produced by superoxide anion from ferric iron (Fig. 1).
Thus, too little SOD can lead to increased availability of both
superoxide anion and reduced iron in favor of hydroxyl radical
formation, whereas excessive SOD can produce hydrogen
peroxide (a precursor of the hydroxyl radical) at a rate in excess
of that at which hydroperoxidases remove it. A delicate balance
must, therefore, be maintained among the availability of super-
oxide, hydrogen peroxide, and reduced iron to minimize the
highly toxic hydroxyl radical formation. In E. coli, the species
studied extensively thus far, the level of SOD is known to be
tightly regulated under a wide range of oxidant stresses to meet
this need [37]. Unequivocal evidence for the functional impor-
tance of SOD in mammalian cells has been provided by studies
using transgenic mice carrying excess SOD gene(s) [38, 39].
Thus, transgenic mice carrying the human Mn-SOD gene (in
addition to their own) were shown to exert prominent resistance
to toxic oxygen exposure, toxicity which would cause pulmo-
nary hemorrhage, hyaline membrane formation and interstitial
edema in wild-type mice [39]. Likewise, transgenic mice with
excess Cu/Zn-SOD genes were found to be highly resistant to
oxidant-induced neuron damage [38]. A most recent human
study on the functional role of SODs includes a combination of
linkage study and sequence analysis of the Cu/Zn-SOD gene in
13 families afflicted with amyotrophic lateral sclerosis [40]. The
results suggest that this progressive degenerative disease of
motor neurons is caused by the toxic effect of reactive oxygen
metabolites which are not appropriately metabolized because of
impaired Cu/Zn-SOD. Whereas Mn-SOD is inducible by a
variety of biological stimuli, the synthesis of Cu/Zn-SOD is
considered largely constitutive [32]. Of interest, a recent study
by Yim, Chock and Stadtman [41] suggests the possibility that
Cu/Zn-SOD can also act as an oxygen radical-generating en-
zyme.
Catalase is present in subcellular peroxisomes and catalyzes
the decomposition of hydrogen peroxide to yield oxygen and
water. Glutathione peroxidase catalyzes the decomposition of
hydrogen peroxide or organic peroxides and reduces glutathi-
one (GSH) which forms oxidized glutathione (GSSG). GSSG is
again reduced to GSH by glutathione reductase, thus forming
the redox cycle. These enzymes are found in both cytosol and
mitochondria.
A new class of antioxidant enzyme has recently become a
focus of intense investigation [42, 43], namely, heme oxygen-
ase, a rate-limiting microsomal enzyme for heme degradation,
that is, utilizing heme as its substrate. Iron is a critical compo-
nent involved in the generation of reactive oxygen metabolites
and lipid peroxidation (Fig. 1). Since not only iron but also
certain hemoproteins (such as cytochrome P-450 and hemoglo-
bin) can promote the formation of hydroxyl radical and lipid
peroxidation [44], this enzyme can serve as an oxidant scaven-
ger by degrading hemoproteins to bile pigments. Moreover, bile
pigments per se can act as important intracellular and extracel-
lular antioxidants [45].
In view of many successful experimental demonstrations of
the therapeutic effectiveness of exogenous antioxidant en-
zymes, clinical applications of AOEs are seriously considered
as important therapeutic measures in many diseases, including
respiratory distress syndrome (both adult and neonatal forms),
acute inflammation, myocardial infarction, stroke, and organ
viability during transplantation [46].
Antioxidant enzymes are regulated to meet biological need
Among antioxidant enzymes, superoxide dismutase has been
studied extensively, particularly in prokaryotes. It intercepts
the first product of the univalent reduction of oxygen molecules
(Fig. 1). Mn-SOD has been shown to be modulated by several
key stimuli, including reactive oxygen metabolites and iron
chelators [47—5 1]. Studies indicate that superoxide and iron
regulate positively and negatively, respectively, transcription of
the Mn-SOD gene. As the bacteriocidal activities of the host's
phagocytic cells (neutrophils, eosinophils and mononuclear
phagocytes) rely on microbial killing by reactive oxygen metab-
olites, induction of SOD in the microorganism is considered an
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Superoxide
dismutase
Table 2. Some of the biological stimulants for superoxide dismutase
in mammalian tissues/cells
Stimulant Tissue/cell
High oxygen tension Lung
Ozone Lung
Paraquat Fibroblast
Hydrogen peroxide Kidney/trachea
Exercise Lung
Endotoxin Lung/kidney/liver
Chiorpromazine Brain
Glucocorticoid Lung/iris/kidney/liver
Heat Lung
TNFfIL.l/IL-6 Lung/kidney/liver/pancreas/intestine
Adapted by permission from CANADA AT, CALABRESE EJ: Superox-
ide dismutase; Its role in xenobiotic detoxification. Pharmac Ther
44:288, 1989
important determinant of their virulence [52]. Catalase in mi-
croorganisms is also known to be multi-regulated in an elabo-
rate fashion [53, 54].
AOEs in eukaryotes are also regulated by multiple factors
[55—60] (Table 2). Following exposure to a variety of nonlethal
oxidant stresses, tissue SOD activity often increases along with
acquisition of resistance to otherwise lethal doses of the same
oxidant stress, a phenomenon seen in both prokaryotes and
eukaryotes [55]. When rats were exposed to 85% oxygen for
seven days, Cu/Zn-SOD and Mn-SOD activities in the lung
increased by 67% and 140%, respectively. When rats were
exposed to 10% oxygen, only Mn-SOD activity increased. Of
interest, when these preexposed rats were subsequently ex-
posed to 100% oxygen, which is otherwise lethal, both of these
groups survived [611. Similar findings have since been obtained
by a number of investigators in their in vivo and in vitro studies
[62—65]. While ozone, another form of oxidant stress, induces
SOD [66], rats exposed to a high concentration of ozone
develop cross-tolerance to a variety of lethal oxidant stresses,
that is, not only to ozone [67] but also to oxygen [68], nitrogen
dioxide [69] and radiation [70].
Of interest to nephrologists, treatment with glucocorticoids is
one of several experimental maneuvers which has been dem-
Fig. 1. Key metabolic pathways of reactive
oxygen metabolites in the cell. Although not
discussed in the text, myeloperoxidase from
neutrophils can metabolize hydrogen peroxide
to produce highly reactive oxidants, most
notably hypochlorite [1]. Other more specific
antioxidant enzymes, although conceivably
important for certain cells, are not included in
this diagram.
onstrated to alter tissue/cell levels of AOEs [7 1—75]. It has been
shown that treatment of pregnant rats in late gestation with
glucocorticoids raises AOE activities in fetal lungs and protects
them against oxygen toxicity [721. In addition, in vitro studies
by Randhawa et al [73, 74] have suggested that glucocorticoids
can act directly on fetal lung explants or fibroblasts in culture to
increase AOE activities. An increase in SOD gene expression,
determined by mRNA, has been shown to occur in response to
several stimuli [76, 77]. Thus, lipopolysaccharide (endotoxin),
interleukin- 1, and tumor necrosis factor have been shown to
raise Mn-SOD mRNA levels in rat pulmonary epithelial cells
[77].
Induction of antioxidant enzymes is considered in the context
of tumor cell malignancy; the increase in AOEs has been
detected in aggressive tumor cell populations [78], suggesting
that this adaptive response may allow the tumor cell to survive
in the environment of high self-generated oxidants [127]. Hu-
man small-cell lung cancer cells exhibit progressive increase in
resistance to oxidant injury [79]. This phenomenon is thought to
underlie the radioresistance seen in many malignant tumors.
Although experimental evidence is at best indirect, antioxidant
enzyme levels are postulated by some investigators to be an
important determinant of a species' life span. By examining the
tissues from 13 different primate species including the human,
Cutler [80] found an impressively linear relationship between
the SOD level and the species' maximum life span potential. In
conjunction with the speculation that aging involves impairment
of the continuous repair of DNA molecules damaged by reac-
tive oxygen metabolites, these investigators were intrigued by
the possibility that the availability of AOEs may be an impor-
tant determinant of a species' life span.
A variety of agents and biological conditions which directly
or indirectly imposes oxidant stress on tissues has been dem-
onstrated to activate heme oxygenase, as well [22, 81—83]. As
heme oxygenase is a heat-shock protein [84], it is expected to
respond to the spectrum of stimuli to which heat-shock proteins
in general are sensitive. Glucocorticoids have also been shown
to induce heme oxygenase in certain settings [81]. Of interest,
when endogenous glutathione peroxidase was experimentally
suppressed by feeding animals with a selenium deficient diet,
Oxygen
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Xanthine oxidase
Lipoxygenase
Cyclooxygenase
NAD(P)H oxidase
Cytochrome P450
Superoxide anion
Water
H20
Catalase
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Hydrogen peroxide
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Hydroxyl radical
OH.
4 Ichikawa et a!: Renal antioxidant enzymes
heme oxygenase was induced in a compensatory manner [221,
suggesting the existence of adaptive responses among different
antioxidant enzymes.
More detailed biological implications of antioxidant enzyme
regulations for non-renal tissues are discussed elsewhere [42,
43, 55, 85].
Endogenous antioxidant enzymes are an essential defense
system against oxidant injury for the kidney
Direct experimental evidence of the importance of AOEs in
renal disease has recently been shown in a study by Nath and
Salahudeen [86] using a diet deficient in selenium, a metal
essential for glutathione peroxidase and other intra- and extra-
cellular AOEs. When animals were raised with a diet deficient
in selenium and vitamin E, they developed renal injury charac-
terized (functionally) by proteinuria and reduced GFR and
(structurally) by interstitial cellular infiltrate. When endogenous
glutathione peroxidase was experimentally depressed in a sim-
ilar manner by a selenium deficient diet [871 or administration of
diethyl maleate [88] in rats treated with puromycin aminonucle-
oside, the characteristic proteinuria was even more markedly
augmented. Of interest, experimental depletion of SOD by
administration of diethyldithiocarbamate was also shown to
aggravate the same purotnycin aminonucleoside nephrosis in
rats [89]. Antioxidant enzymes may operate as a renal protec-
tive mechanism through yet another channel. Given that the
kidney under oxidant stress is characterized by a profound
vasoconstriction [90] and that nitric oxide acts as a potent
vasodilator [91] readily degraded by superoxide anion [921,
antioxidants, particularly SODs (through their ability to scav-
enge superoxide anion), can maximize the renal protective
action of nitric oxide [931. Convincing evidence for the protec-
tive role of SODs of endogenous origin was provided in a study
with transgenic mice carrying additional SOD gene(s). Morpho-
logic analysis of the kidney following experimental transient
ischemialreperfusion in these mice revealed a distinctive pat-
tern of tissue protection from injury [941.
Acute renal failure secondary to severe rhabdomyolysis is
another clinical setting in which oxidant stress plays a major
pathogenic role since, in the experimental rhabdomyolysis
induced by administration of glycerol, the characteristic depres-
sion of GFR can be ameliorated by exogenous administration of
dimethyithiourea, a hydroxyl radical scavenger, or deferoxam-
me [17, 95]. The importance of heme oxygenase in this setting
was convincingly demonstrated in a recent study using tin-
protoporphyrin, a competitive inhibitor of heme oxygenase
[96]. In this study, animals with mild glycerol-induced rhabdo-
myolysis developed severe azotemia only when they had been
pretreated with tin-protoporphyrin [96].
Collectively, studies point to the highly significant role of
endogenous AOEs as an effective defense mechanism against
oxidative renal injury.
Renal antioxidant enzymes are also regulated
Similar to other cells, renal cells respond to many biological
stimuli, including reactive oxygen metabolites, with increased
AOE activities [97]. Cultured rat glomerular mesangial cells
incubated with hydrogen peroxide were shown, in a preliminary
study, to have Mn-SOD activity significantly elevated over the
level of untreated cells, while there was no difference in
Cu/Zn-SOD activity between hydrogen peroxide-treated and
untreated cells [98]. These phenomena were identified in vivo;
by assessing specific lipid hydroperoxides with a sensitive
method, a 30-minute complete renal ischemia followed by
reperfusion was shown to impose significant oxidant stress on
the kidney [18]. Glomeruli isolated from rats subjected to the
above ischemialreperfusion protocol had elevated levels of
antioxidant enzyme activities [99]. Thus, the activities of total
SOD, Mn-SOD, glutathione peroxidase, and catalase were
uniformly increased over control levels. These effects appeared
somewhat selective, as the LDH (cytosolic enzyme) and fuma-
rase (mitochondrial enzyme)—both non-AOE enzymes—mea-
sured in the experiments were unaffected [99]. In the absence of
data on renal tubules, it is speculated, without evidence, that
AOEs were also induced in the renal tubules, the major target of
renal ischemiaJreperfusion injury.
As in the lung, renal AOEs are also up-regulated by gluco-
corticoids. Of interest, glucocorticoid pretreatment of rat gb-
merular mesangial cells cultured in vitro was shown, after a lag
period, to decrease the hydrogen peroxide released when cells
were exposed to zymosan [13]. Glomeruli isolated from rats
given a daily injection of methylprednisobone for three to nine
days were found to have significantly higher activities of total
SOD, Mn-SOD, glutathione peroxidase, and catalase than those
from untreated rats [251. In a subsequent study, glomerular
endothelial cells were incubated in vitro with or without meth-
ylprednisolone, and antioxidant enzyme activities were deter-
mined 24 hours later. Mn-SOD and catalase activities were
significantly elevated in methylpreclnisolone-treated cells, al-
though Cu/Zn-SOD or glutathione peroxidase activity was not
appreciably affected in these experiments [1001,
Renal antioxidant enzymes can be down-regulated, as well,
by certain biological stimuli. When antioxidant enzyme activi-
ties in renal cortex were compared between acutely water
deprived and non-water deprived rats, water deprived rats were
found to have catalase and superoxide dismutase activities that
were reduced to —50% of baseline levels [101].
Renal antioxidant enzymes undergo postnatal development.
Oberley et at demonstrated immunohistochemical localization
of SODs and catalase in the developing hamster kidney [102].
They found no positive staining before birth and a postnatal
increase in immunoreactive enzymes which developed in a
centrifugal pattern; positive staining first appeared in the jux-
tamedullary region and then extended to superficial nephrons.
In contrast, the brain and heart demonstrated constant staining
of the enzymes. Similar findings were described in the fetal rat
kidney using radioimmunoassay for SODs [103].
Exposure of the kidney to exogenous hemoglobin or, more
indirectly, endogenous myogbobin induced by glycerol admin-
istration was shown to increase local heme oxygenase activity
and mRNA expression of this antioxidant enzyme, while this
adaptive response was not seen in catalase or glutathione
peroxidase [96]. Using hydrogen peroxide, reactive oxygen
metabolites have been shown to induce heme oxygenase in
proximal tubule cells in vitro [1041.
Recent studies by several investigators have been directed
toward evaluating the functional significance of these renal
antioxidant enzyme regulations. The experimental evidence
heretofore collected, although still limited, is suggestive of a
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broad pathophysiologic and therapeutic significance of AOE
regulation, as discussed below.
Pathophysiologic and therapeutic implications of renal
antioxidant enzyme regulation
Some forms of acute renal insult which involve generation of
reactive oxygen metabolites in kidneys induce a resistance to
recurrent insults of a similar nature [1051. Given that reactive
oxygen metabolites induce activation of AOEs, not only in
prokaryotic but also mammalian cells (both renal and non-
renal), as discussed above, it is conceivable that this acquisition
by the kidney of resistance to reactive oxygen metabolites may
involve enhancement of local levels of AOEs. This possibility
has been tested recently in some models of renal oxidant injury.
Rats, in which glomerular AOE activities were raised by a
30-minute complete renal ischemia followed by reperfusion,
were rechallenged six days later with either 30 minutes of
ischemia plus 60 minutes of reperfusion or unilateral intrarenal
arterial infusion of hydrogen peroxide [99]. Whereas in normal
control rats these experimental manipulations induced severe
reductions in GFR and massive proteinuria, respectively, those
with elevated AOEs were protected from these functional
deteriorations. Thus, enhanced local AOE activities induced by
exposure to reactive oxygen metabolites provided kidneys with
an effective defense system against the toxic effect of reactive
oxygen metabolites.
As discussed earlier, heme oxygenase, which has been shown
to act as an important endogenous antioxidant in acute renal
failure secondary to rhabdomyolysis, can be induced by hemo-
globin [961. The functional significance of this induction was
verified by the observation that animals with enhanced heme
oxygenase by hemoglobin pretreatment became resistant to the
development of severe azotemia and tubular necrosis charac-
teristic of an experimental rhabdomyolysis, although the heme
oxygenase induction did not bring about a cross tolerance to
other forms of oxidant stress, that is, ischemiaireperfusion [96].
Together with the concurrent up-regulation of ferritin [96], an
iron binding protein which serves to minimize the toxic effect of
the irons freed from heme, heme oxygenase induction by iron
pigments confers a significant protection against a specific form
of renal oxidant injury.
Glucocorticoids constitute the first-line treatment of neph-
rotic syndrome and are remarkably effective in treating minimal
change nephrotic syndrome [106]. The mechanism by which
glucocorticoids bring minimal change nephrotic syndrome into
remission has not been clarified. While glucocorticoids can
affect the function of infiltrating cells (such as, neutrophils) by
suppressing the generation of reactive oxygen metabolites
produced during phagocytosis [13], minimal change disease
lacks clear evidence for local cell infiltration or inflammatory
processes. Of interest, glucocorticoids have also been shown to
be protective in an animal model of nephrotic syndrome, that is,
puromycin aminonucleoside nephrosis (PAN) although, unlike
the human counterpart, this animal model lacks evidence of T
cell activation through which glucocorticoids may potentially
work [107]. As discussed earlier, glucocorticoids can raise
glomerular antioxidant enzyme activity in vivo [25]and in vitro
[100]. Importantly, when glomerular antioxidant enzyme activ-
ity was raised by daily administration of methylprednisolone,
animals acquired resistance to the toxic effect of a direct
intrarenal arterial injection of hydrogen peroxide, which other-
wise would have induced massive proteinuria in normal un-
treated animals [25]. Indeed, the above-discussed rats with
PAN nephrosis, which had been treated with glucocorticoids,
showed less impairment in renal function, lacked the typical
morphologic feature of fusion of glomerular epithelial foot
processes, and had lower glomerular lipid peroxidation product
levels, an index of oxidant stress [25]. Overall, the mechanism
for therapeutic effect of glucocorticoids on minimal change
nephrotic syndrome appears to include an enhancement of
endogenous glomerular AOEs, which attenuates the production
of reactive oxygen metabolites within the glomerular tissue.
Given that polymorphonuclear leukocytes are involved in some
inflammatory processes of renal parenchymal and microvascu-
lar lesions, the capacity of glucocorticoids to induce MnSOD in
these circulating cells [108] may also contribute to minimizing
the oxidative injuries caused by the oxygen radicals released
from these cells [109].
Speculated molecular mechanisms for renal antioxidant enzyme
regulation
The mechanism regulating antioxidant enzyme levels in mam-
malian cells is the focus of current intense investigation. In this
regard, transcriptional regulation appears to be at least a part of
the mechanism of local antioxidant enzyme regulation [77, 110,
111]. Thus, in addition to the experimental evidence for up!
down-regulation of AOE activities and protein contents, there
are several experimental studies reporting regulated expression
of AOE genes. In general, regulation of protein (that is,
enzyme) synthesis can occur at one of several steps: transcrip-
tion; processing (of RNA transcripts); stabilization (of mRNA);
translation and post-translation [112]. Among these, the rate of
transcription is the most common step for regulating specific
gene expression. In fact, the gene expressions of several
hormones or enzymes have been shown to be regulated by
oxidants or local oxygen tension in non-renal tissues, including
the lung, cardiomyocytes [113], and erythropoetin-producing
hepatoma cells [11]. Many regulatory elements for transcription
may be located adjacent to the promoter region and may act as
activators to turn on (or off) the functional promoters. It is
within these regulatory elements that the response elements for
a variety of steroid hormones and other regulators reside [11,
115—122]. Along with the nucleotide sequence, several impor-
tant functional features of this regulatory element have been
clarified for the Mn-SOD gene in prokaryotes [37].
Regulation of gene expression by steroid hormones is thought
to proceed as follows [112, 115]: (1) ligand-receptor binding; (2)
activation of the steroid receptor and transformation; (3) bind-
ing of the hormone-receptor complex with a specific DNA
sequence (in the regulatory region); and (4) changes in the rate
of transcription. While much of the published data have been
consistent with a primary effect of steroid hormones at the level
of gene transcription, it is possible that, in some circumstances,
the rate of transcription remains relatively constant during
protein induction and that the accumulation of mRNA is due
simply to a steroid-induced suppression of mRNA degradation
[112, 115] or activation of translation. The latter has recently
been reported for the regulation of Na-K-ATPase subunit by
glucocorticoids [123].
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The binding sites for the glucocorticoids-receptor complex,
or glucocorticoid response element (GRE), have been studied
on various genes in various cells [116—122]. The binding sites
are usually located between 40 to 2,700 bp upstream of the
transcription initiation site [116—120, 1221. Several nucleotide
sequences have been identified for GRE [112, 116, 122, 124]:
GRE contains an imperfect palindromic consensus sequence
with a highly conserved core hexanucleotide (such as 5'-
TGTTCT-3' or 5'-TGTCCT-3'). Within the rat Mn-SOD gene,
there are at least two sequences relevant to the core hexanu-
cleotide of GRE in the upstream region, one of which has a
palindromic structure (Fig. 2) [1241. It is, therefore, possible
that glucocorticoids activate the Mn-SOD gene by involving
these GREs. A recent preliminary study demonstrated en-
hancement of Mn-SOD activity and mRNA content in methyl-
prednisolone-treated cultured glomerular cells [100]. Therefore,
within the glomerulus, glucocorticoids are likely to regulate
antioxidant enzyme levels at the gene transcriptional step, as
they do for other proteins [115, 1251.
The acquisition by the kidney of functionally important
elevated antioxidant enzyme levels following exposure to oxi-
dant stress (discussed earlier) may also involve activation of
local antioxidant enzyme genes. LLC-PK1 (proximal tubule
cell-like cells derived from the porcine kidney) cells exposed to
hydrogen peroxide have been shown to have enhanced mRNA
expression of heme oxygenase [104]. Renal epithelial cell lines
exposed to hydrogen peroxide chronically acquire elevated
catalase and glutathione peroxidase levels [1261. The Mn-SOD
mRNA level in rat mesangial cells was significantly elevated
after exposure to hydrogen peroxide [98]. As described earlier,
in addition to oxygen radicals per se, some cytokines, for
example, TNF-a, IL-i and IL-6, have been shown to transcrip-
tionally up-regulate SOD in a manner somewhat specific to the
cell type (Table 2). As these cytokines play key roles in tissue
inflammatory and immune responses, as well as multiple other
biological phenomena, the mechanism of this cytokine-induced
transcriptional activation has been a focus of a great interest.
Thanks to recent research endeavors several intermediary steps
have been identified for a few genes. Studies have identified
NF-icB, a multisubunit transcription factor protein which, in
collaboration with cell-specific factors, can activate the expres-
sion of the cytokine genes described above [1271. Since TNF-a
fails to activate NF-KB when cells are concurrently treated with
antioxidants [128], reactive oxygen species appear to be the
secondary messenger for cytokine activation of NF-KB and to
act as its direct activator. Of note, TNF-a activates NF-icB and
the Mn-SOD gene in human papillary thyroid carcinoma cells
[129]. Moreover, the Mn-SOD gene contains, in its upstream
region (Fig. 2), a concensus decanucleotide sequence which has
been determined in other genes to be the binding site for NF-KB
Fig. 2. Putative nuclear factor ,cB (NF-KB)
binding site, glucocorticoid response elements
(GRE), and oxygen radical response element
(ORE) on the rat man ganese-superoxide
dismutase (Mn-SOD) gene.
[131]. The possibility exists, therefore, that activation of
NF-icB, followed by its binding to its recognition site, is
involved in the transcriptional up-regulation of the Mn-SOD
gene by oxygen radicals. Alternatively, activation of the Mn-
SOD gene may involve a separate set of unknown binding
protein and nucleotide elements responsive to oxygen radical
species.
Of interest, in this regard, recent studies have identified a
nucleotide consensus sequence (GTACNNNGC) linked to an
enhancement in transcription of the rat glutathione-S-trans-
ferase Ya subunit gene in response to hydrogen peroxide [130].
This consensus sequence is present in a non-coding region of rat
Mn-SOD genomic DNA (Fig. 2).
Collectively, recent studies point to the notion that the
kidney inherits and acquires a powerful defense system against
oxidant injuries which responds to a variety of natural and
therapeutic stimuli. Insight into such alterations of the antiox-
idant system may unwind the mechanism and therapeutic
approach to a variety of renal injuries.
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